drugset / Trial / NCT06168994
Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease
RandomizedParallel-groupSingle-blindPrevention
Summary
The aim of this study is to study synergistic effect of eplerenone as Selective aldosterone receptor antagonist with amiodarone compared with amiodarone only in reducing recurrence of atrial fibrillation in patient with structural heart disease
Timeline
- Start
- 2024-02-01
- Primary completion
- 2026-09-29
- Completion
- 2027-05-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eplerenone | Unknown | — | — |